William Blair Starts Spring Bank Pharmaceuticals (SBPH) at Outperform
- Wall St. slips on President Trump's protectionist views
- Aetna's (AET) Humana (HUM) Takeover Blocked by Judge as Anticompetative - Bloomberg
- Trump signs order withdrawing U.S. from Trans-Pacific trade deal
- Qualcomm (QCOM) Thrashed as Apple (AAPL) Lawsuit Threatens Licensing Business Model
- McDonald's (MCD) Tops Q4 EPS by 3c
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
William Blair initiated coverage on Spring Bank Pharmaceuticals (NASDAQ: SBPH) with an Outperform rating.
Shares of Spring Bank Pharmaceuticals closed at $11.02 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Expect Twilio (TWLO) To Exceed Baseline Revenue Estimates, 2017 Guidance Likely Conservative - William Blair
- Credit Suisse Starts Molson Coors (TAP) at Neutral
- Craig-Hallum Starts GrubHub Inc. (GRUB) at Hold
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesWilliam Blair
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!